Heddiw, rwy'n cyhoeddi cynnydd yn y cyllid ar gyfer gwasanaethau Adferiad o £5m i £8.3m o fis Ebrill 2023. Bydd hyn yn helpu i ehangu mynediad “ar sail anghenion" neu "ar sail symptomau" ar gyfer pobl sydd â chyflyrau hirdymor eraill y mae eu hanghenion adsefydlu ac adfer yn debyg i anghenion pobl sydd â Covid Hir – er enghraifft, pobl sydd ag enseffalomyelitis myalgig/syndrom blinder cronig (ME/CFS), ffibromyalgia a chyflyrau ôl-feirysol cysylltiedig eraill.
Today, I am announcing an increase in funding for Adferiad services from £5m to £8.3m from April 2023. This will support a widening of access on a “needs led” or “symptom led” basis for people with other long-term conditions whose rehabilitation and recovery needs are similar to people with long-Covid – for example, people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), fibromyalgia and other post-viral associated conditions.